Antithymocyte globulin versus basiliximab induction for kidney transplantation in elderly patients: matched analysis within the Korean multicentric registry

• Egile Nagusiak: Jun Young Lee (Egilea), Sung Hwa Kim (Egilea), Yeon Ho Park (Egilea), Jae Berm Park (Egilea), Su Hyung Lee (Egilea), Jaeseok Yang (Egilea), Myoung Soo Kim (Egilea), Deok Gie Kim (Egilea)
• Formatua: Liburua
• Argitaratua: The Korean Society of Nephrology, 2022-09-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Background Basiliximab (BSX) and antithymocyte globulins (ATGs), are two major immunosuppressive agents commonly used as induction therapy for kidney transplant (KT) recipients. The superiority of ATG over BSX has not been well established, especially in elderly KT recipients with low immunological...